CIK: 0001833486
Total reported value
$100.7M
Reporting period: 2026-03-31 · Number of holdings: 3
Column Group LLC disclosed 3 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $100.7M and a quarterly turnover rate of 45.6%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "C"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/column-group-llc
Add ORIC
0.0% $15.9M
Add 86889P109
+3.5% $14.0M
Sold out TNYA
Sold out 75382E109
Unchanged RVMD
0.0% $810.0
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Surrozen, Inc. | Stock-Other | 55.45% | +4.91% | +3.54% | |
| 2 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 44.55% | +9.57% | — | |
| 3 | RVMD | Revolution Medicines INC | Stock-Healthcare | — | — | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 0% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings | |
|---|---|---|---|---|---|
| 2026 Q1 | 3 | $100.7M | 46 | ||
| 2025 Q4 | 5 | $82.8M | 55 | ||
| 2025 Q3 | 5 | $81.0M | 50 | ||
| 2025 Q2 | 5 | $65.7M | 0 | ||
| 2025 Q1 | 5 | $44.2M | 100 | ||
| 2024 Q4 | 5 | $55.7M | 0 | ||
| 2024 Q3 | 6 | $69.6M | 0 | ||
| 2024 Q2 | 6 | $71.3M | 0 | ||
| 2024 Q1 | 7 | $160.5M | 0 | ||
| 2023 Q4 | 6 | $151.4M | 0 | ||
| 2023 Q3 | 7 | $150.6M | 0 | ||
| 2023 Q2 | 7 | $257.7M | 0 | ||
| 2023 Q1 | 7 | $276.6M | 0 | ||
| 2022 Q4 | 7 | $300.4M | 0 | ||
| 2022 Q3 | 7 | $451.8M | 0 | ||
| 2022 Q2 | 7 | $469.9M | 0 | ||
| 2022 Q1 | 7 | $539.4M | 0 | ||
| 2021 Q4 | 7 | $735.3M | 0 | ||
| 2021 Q3 | 7 | $879.1M | 0 | ||
| 2021 Q2 | 5 | $706.5M | 53 | ||
| 2021 Q1 | 6 | $1.0B | 11 | ||
| 2020 Q4 | 7 | $1.1B | 0 |
Column Group LLC's most significant position changes for 2026-03-31: Sold out: Tenaya Therapeutics INC (TNYA); Sold out: Rapt Therapeutics INC; Add: Surrozen, Inc. — shares +3.54%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ORIC | Oric Pharmaceuticals INC | +9.6% | — | Unchanged |
| 2 | ✓ | Surrozen, Inc. | +4.9% | +3.54% | Add |
| 3 | RVMD | Revolution Medicines INC | — | — | Unchanged |
| 4 | TNYA | Tenaya Therapeutics INC | — | EXIT | Sold out |
| 5 | ✓ | Rapt Therapeutics INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026 Q1 | 2026-05-18 | 13F-HR | View on EDGAR |
| 2025 Q4 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025 Q3 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025 Q2 | 2025-08-15 | 13F-HR | View on EDGAR |
| 2025 Q1 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024 Q4 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024 Q3 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024 Q2 | 2024-08-15 | 13F-HR | View on EDGAR |
| 2024 Q1 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023 Q4 | 2024-02-09 | 13F-HR | View on EDGAR |
| 2023 Q3 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023 Q2 | 2023-07-24 | 13F-HR | View on EDGAR |
| 2023 Q1 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022 Q4 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022 Q3 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022 Q2 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022 Q1 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021 Q4 | 2022-02-11 | 13F-HR | View on EDGAR |
| 2021 Q3 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021 Q2 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021 Q1 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020 Q4 | 2021-02-16 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002102009
Total reported value
$100.7M
53 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002040263
Total reported value
$100.7M
12 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001846333
Total reported value
$100.7M
51 stks
2023-06-30
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
Access Column Group LLC's institutional profile programmatically:
REST API
curl https://alphasmo.com/api/v1/institutions/column-group-llcCLI
npx alphasmo institutions get column-group-llc